Procalcitonin has now been shown to be a valuable tool in the current COVID-19 pandemic to quickly identify patients at low risk for bacterial coinfection and adverse outcome. Learn more https://t.co/0Oqz55t22T #PCT #Procalcitonin #COVID pic.twitter.com/SQ1WnSuC1l

— Thermo Fisher (@thermofisher) April 21, 2020